您的位置: 首页 > 农业专利 > 详情页

BIOMARKERS OF METHOTREXATE-INDUCED IMMUNE TOLERANCE
专利权人:
GENZYME CORPORATION
发明人:
JOSEPH, Alexandra,TRAN, Johnson,RICHARDS, Susan M.
申请号:
SG11202005810W
公开号:
SG11202005810WA
申请日:
2018.12.21
申请国别(地区):
SG
年份:
2020
代理人:
摘要:
The present application provides methods of treating a disease, such as Pompe disease, in a subject, comprising detecting an erythropoiesis biomarker in a sample of the subject after administration of methotrexate and a therapeutic agent to the subject, and administering further treatment with or without concurrently administering additional immune tolerance induction or immunosuppression therapy based on the level of the erythropoiesis biomarker. Further provided by the present application are methods and kits for assessing the level of immune tolerance to a therapeutic agent in a subject based on detection of an erythropoiesis biomarker after administration of methotrexate and the therapeutic agent to the subject.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充